Evidence map›Paper›PMID 34160785›Full record

ReviewTherapeutic innovation & regulatory science2021

Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.

Chengxing Cindy Lu, Xiaoyun Nicole Li, Kristine Broglio, Paul Bycott, Qi Jiang, Xiaoming Li, Anna McGlothlin, Hong Tian, Jingjing Ye

Abstract readReview
In one paragraph

Review in Therapeutic innovation & regulatory science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Glycaemic control in labour with diabetes: GILD, a scoping study.Health technology assessment (Winchester, England) · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chengxing Cindy Lu *Analytics and Data Sciences, Biogen Inc, 300 Binney St, Cambridge, MA, 02142, USA. cindy.lu@biogen.com.ORCID 0000-0003-2155-5323
Xiaoyun Nicole Li *Biostatistics and Research Decision Sciences, Merck & Co., Inc, Kenilworth, NJ, 07033, USA.
Kristine BroglioAstraZeneca, Gaithersburg, MD, 20878, USA.
Paul BycottGlobal Biometrics and Data Management, Pfizer Inc, La Jolla, CA, 92121, USA.
Qi JiangBiometrics, Seagen, Bothell, WA, 98021, USA.
Xiaoming LiAtara Biotherapeutics, South San Francisco, CA, 94080, USA.
Anna McGlothlinStatistics & Software Team, Berry Consultants LLC, Austin, TX, 78746, USA.
Hong TianStatistics and Decision Sciences, Janssen, Raritan, NJ, 07920, USA.
Jingjing YeGlobal Statistics and Data Sciences, BeiGene, Fulton, MD, 20759, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Master protocol, categorized as basket trial, umbrella trial or platform trial, is an innovative clinical trial framework that aims to expedite clinical drug development, enhance trial efficiency, and eventually bring medicines to patients faster. Despite a clear uptake on the advantages in the concepts and designs, master protocols are still yet to be widely used. Part of that may be due to the fact that the master protocol framework comes with the need for new statistical designs and considerations for analyses and operational challenges. In this article, we provide an overview of the master protocol framework, unify the definitions with some examples, review the statistical methods for the designs and analyses, and focus our discussions on some practical considerations and recommendations of master protocols to help practitioners better design and implement such studies.

Indexed as

Research DesignAdaptive Clinical Trials as TopicHumansAdaptive designBasket trialComplex clinical trialMaster protocolPlatform trialUmbrella trial

Identifiers

PMID34160785
PMCPMC8220876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.